This study evaluated actual physician-reported treatments for advanced BC in Europe.

This design will be used to produce additional, advanced BC families to further refine this QTL localization.

Patients and methods: Thirty-four women with advanced BC, aged 32-75 years (median 59), previously untreated for recurrence, were enrolled in the study.